Last $43.43 USD
Change Today -0.02 / -0.05%
Volume 273.5K
WST On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

west pharmaceutical services (WST) Snapshot

Open
$43.41
Previous Close
$43.45
Day High
$43.61
Day Low
$43.25
52 Week High
01/17/14 - $51.12
52 Week Low
09/6/13 - $36.77
Market Cap
3.1B
Average Volume 10 Days
346.1K
EPS TTM
$1.61
Shares Outstanding
70.8M
EX-Date
10/20/14
P/E TM
26.9x
Dividend
$0.44
Dividend Yield
0.92%
Current Stock Chart for WEST PHARMACEUTICAL SERVICES (WST)

Related News

No related news articles were found.

west pharmaceutical services (WST) Related Businessweek News

No Related Businessweek News Found

west pharmaceutical services (WST) Details

West Pharmaceutical Services, Inc. develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The Pharmaceutical Packaging Systems segment offers packaging components and systems for injectable drug delivery, such as stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. This segment also provides contract analytical laboratory services for testing and evaluating primary drug packaging components with the contained drug formulation; and specialized testing for complete drug delivery systems. The Pharmaceutical Delivery Systems segment offers safety and administration systems, and multi component systems for drug administration. This segment offers customer contract-manufacturing and assembly solutions, which include technologies, such as multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding and device assembly used to manufacture customer-owned components, as well as devices used in surgical, diagnostic, ophthalmic, other drug delivery systems, personal care, and consumer products. This segment’s administration systems comprise sterile devices for the administration of drug products, including transfer devices, needleless reconstitution systems, and vial adapters. The company sells its products through its sales force, distribution network, contract sales agents, and regional distributors in the United States, Germany, France, and other European countries. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

6,900 Employees
Last Reported Date: 02/27/14
Founded in 1923

west pharmaceutical services (WST) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $825.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.9K
President of Pharmaceutical Packaging Systems...
Total Annual Compensation: $359.3K
President of Pharmaceutical Delivery Systems
Total Annual Compensation: $339.9K
Compensation as of Fiscal Year 2013.

west pharmaceutical services (WST) Key Developments

West Pharmaceutical Services, Inc. Announces Resignation of Jeffrey C. Hunt as President, Pharmaceutical Packaging Systems, Effective from July 27, 2014

West Pharmaceutical Services, Inc. announced that Jeffrey C. Hunt, President, Pharmaceutical Packaging Systems, resigned on July 27, 2014. Mr. Hunt joined the company in 2010. The division will report directly to Dr. Morel while the company evaluates candidates for his replacement.

West Pharmaceutical Services, Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Half Year Ended June 30, 2014; Reaffirms Earnings Guidance for the Year 2014; Provides Earnings Guidance for the Third Quarter of 2014

West Pharmaceutical Services, Inc. announced unaudited consolidated financial results for the second quarter and half year ended June 30, 2014. For the quarter, net sales were $368.9 million against $344.5 million a year ago. Operating profit was $54.1 million against $42.5 million a year ago. Income before income taxes was $50.4 million against $38.8 million a year ago. Net income was $37.6 million or $0.52 per diluted share against $30.2 million or $0.43 per diluted share a year ago. As a result of the improved operating results and despite the higher tax rate, diluted EPS grew by 20.9%. For the half year, net sales were $715.7 million against $683.9 million a year ago. Operating profit was $93.4 million against $85.9 million a year ago. Income before income taxes was $86.1 million against $78.0 million a year ago. Net income was $64.7 million or $0.89 per diluted share against $61.9 million or $0.88 per diluted share a year ago. Operating cash flow was $73.0 million against $98.4 million a year ago. Capital expenditures were $56.2 million against $83.8 million a year ago. The company confirmed prior guidance for 2014 diluted EPS in the range of $1.77 to $1.89 on forecasted consolidated sales growth of 4% to 6% over last year, excluding currency effects. The company estimates consolidated net sales of $1,430 million to $1,460 million against prior guidance of $1,450 million to $1,480 million and consolidated gross profit margin of 32.0% to 32.5% against prior guidance of 31.9% to 32.4%. The estimated annual effective tax rate (ETR) for 2014 is 27.7%, compared to 26.5% used in determining second-quarter 2013 results. The increase is due to the expiration of the U.S. research tax credit at the end of 2013 and changes in the expected geographic mix of 2014 earnings. The company expects to spend approximately $125 million to $145 million in capital in 2014. The company expects modest EPS gains for third quarter versus the record 2013 quarter.

West Pharmaceutical Services, Inc. to Report Q2, 2014 Results on Jul 31, 2014

West Pharmaceutical Services, Inc. announced that they will report Q2, 2014 results on Jul 31, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $43.43 USD -0.02

WST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Catalent Inc $21.50 USD 0.00
Chemed Corp $105.61 USD +1.63
Gerresheimer AG €54.98 EUR -0.38
Hill-Rom Holdings Inc $43.81 USD +0.01
STERIS Corp $56.29 USD +0.49
View Industry Companies
 

Industry Analysis

WST

Industry Average

Valuation WST Industry Range
Price/Earnings 27.3x
Price/Sales 2.2x
Price/Book 3.2x
Price/Cash Flow 26.7x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit www.westpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.